文献速递临床试验与 GCP基础与转化研究

定制认知行为疗法与支持性倾听干预对新诊断多发性硬化抑郁患者的疗效比较:ACTION-MS试验方案

Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial.
PubMed 文献 · Trials · 2020-01-20

BACKGROUND: Multiple sclerosis (MS) is an unpredictable, chronic neurological disease accompanied with high rates of depression and anxiety, particularly in the early stages of diagnosis.…

要点

  • 针对新诊断多发性硬化伴轻中度抑郁患者,比较定制CBT与支持性倾听的疗效。
  • 主要结局为干预后BDI-II抑郁严重程度,按意向性分析。
  • 将提供效应量估计,为后期多中心疗效试验提供样本量依据。

核心结论

  • 该试验将评估定制CBT相比支持性倾听对新诊断多发性硬化抑郁患者的疗效与成本效果。

研究设计与样本

  • 双臂平行组、评估者盲法、阳性对照的随机对照试验。

关键数值与推荐

  • 主要结局为干预后BDI-II抑郁严重程度。
  • 将评估干预满意度与可接受性,并进行成本效果分析。
  • 数据按意向性分析。

临床怎么用

  • 若有效,定制CBT可在门诊MS诊所用于新诊断期抑郁干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple sclerosis (MS) is an unpredictable, chronic neurological disease accompanied with high rates of depression and anxiety, particularly in the early stages of diagnosis. There is evidence to suggest that cognitive behavioural therapy (CBT) is effective for the treatment of depression amongst individuals with MS; however, there is a paucity of tailored CBT interventions designed to be offered in the newly diagnosed period. This trial is the first to assess the effectiveness and cost-effectiveness of a tailored CBT intervention compared to a supportive listening (SL) intervention amongst individuals with MS who are depressed. METHODS: ACTION-MS is a two-arm parallel group, assessor-blinded, active comparator, randomised controlled trial which will test whether a tailored CBT-based intervention compared to an SL intervention can reduce depression and related factors such as anxiety, fatigue, pain and sleep problems in those newly diagnosed with MS. Sixty participants who are within 5 years of having received a diagnosis of MS and scored within the mild to moderate range of depression on the Beck Depression Inventory (BDI-II) will be recruited from MS clinics located across three hospital sites in Melbourne, Australia. The primary outcome is depression severity using the BDI-II at post-assessment. Intervention satisfaction and acceptability will be assessed. A cost-effectiveness analysis will also be conducted. Data will be analysed on an intention-to-treat basis. DISCUSSION: There is a scarcity of psychological interventions for depression targeting the newly diagnosed period. However, interventions during this time point have the potential to have a major impact on the mental and physical wellbeing of those newly diagnosed with MS. The current trial will provide data on the effectiveness of a tailored CBT intervention for the treatment of depression in those newly diagnosed with MS. Findings will also provide effect size estimates that can be used to power a later-stage multi-centre trial of treatment efficacy, and will provide information on the mechanisms underlying any treatment effects and cost-effectiveness data for delivering this intervention in outpatient MS clinics. TRIAL REGISTRATION: ISRCTN trials registry, ISRCTN63987586. Current controlled trials. Retrospectively registered on 20 October 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kiropoulos L, Kilpatrick T, Kalincik T, et al. Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, active comparator, randomised controlled trial. Trials. 2020. PMID: 31959224. doi:10.1186/s13063-019-4018-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。